Comparative effect of (S) -1- (3-hydroxy-2-phosphonylmethoxypropyl) cytosine and 9- (1,3-dihydroxy-2-propoxymethyl) guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats
Stals, F.S.; Zeytinoglu, A.; Havennith, M.; de Clercq, E.; Bruggeman, C.A.
Transplantation Proceedings 25(1 Part 2): 1248-1249
1993
ISSN/ISBN: 0041-1345 PMID: 8382855 Document Number: 418587
Document emailed within 1 workday
Related Documents
Böcher, W.O.; Schirmacher, P.; Löhr, H.F.; Kolbe, K.; Wanitschke, R.; Meyer zum Büschenfelde, K.H. 1995: Hepatic manifestation of hemolytic uremic syndrome in an allogeneic bone marrow transplant recipient Zeitschrift für Gastroenterologie 33(9): 543-545Sparrelid, E.; Emanuel, D.; Fehniger, T.; Andersson, U.; Andersson, J. 1997: Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity Transplantation 63(12): 1782-1789
Cooper, M.H.; Maraninchi, D.; Gastaut, J.A.; Mannoni, P.; Carcassonne, Y. 1993: HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population Journal of Acquired Immune Deficiency Syndromes 6(3): 277-284
Piatkin, E.K.; Baranov, A.E. 1977: Chromosome lesions caused by cyclophosphane in the bone marrow cells of a female aplastic anemia patient in the process of preparation for an allogeneic bone marrow transplant Problemy Gematologii i Perelivaniia Krovi 22(3): 12-16
Bursztyn, M.; Zelig, O.; Or, R.; Nagler, A. 1997: Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study Transplantation 63(7): 1034-1036
Pérez, M.C.; Campos-Herrero, M.I.; Mataix, R.; Elcuaz, R.; Gómez-Casares, T.; Pena, J.M.; Campo, C. 1994: Fusarium sp. disseminated infection in a allogeneic bone marrow transplantation recipient Enfermedades Infecciosas y Microbiologia Clinica 12(7): 358-360
Lehn, P.; Quessar, A.; Devergie, A.; Esperou-Bourdeau, H.; Traineau, R.; Trédaniel, J.; Benbunan, M.; Bussel, A.; Jolivet, I.; Mazeron, M.C. 1990: Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. a pilot study Nouvelle Revue Francaise d'Hematologie 32(1): 17-20
Nguyen, B.T.; Lortscher, D.N.; Lee, R.A. 2012: Multiple poromas in a bone marrow transplant recipient: A case report Dermatology Online Journal 18(7): 9
Ghiasian, S.A.; Maghsood, A.H.; Mirhendi, S.H. 2006: Disseminated, fatal Trichosporon asahii infection in a bone marrow transplant recipient Journal of Microbiology Immunology and Infection 39(5): 426-429
Barbara, J.A.; Thomas, A.C.; Smith, P.S.; Gillis, D.; Ho, J.O.; Woodroffe, A.J. 1992: Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient Clinical Nephrology 37(3): 115-118
Mehta, J.; Powles, R.; Horton, C.; Milan, S.; Singhal, S.; Treleaven, J. 1995: Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings Bone Marrow Transplantation 15(6): 853-858
Bleiberg, I.; Ricciardone, M.D.; Reddi, H.A.; McCarthy, K.F. 1987: New bone formation and bone marrow differentiation induced in rats by extracellular bone matrix implantation: effect of local preirradiation on the process Experimental Hematology 15(4): 309-315
Zakrzewski, J.L. 2002: Successful management of impending late graft failure in a thalassemic bone marrow transplant recipient Haematologica 87(10): Ecr32
Spaner, D.; Lowsky, R.; Fyles, G.; Lipton, J.H.; Banerjee, D.; Ng, C.M.; Wade, J.A.; Messner, H.A. 1998: Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient Transplantation 66(9): 1251-1253
Hinterberger, W.; Höcker, P.; Kallinger, W.; Alth, G.; Kolbabek, H.; Emminger, W.; Volc-Platzer, B.; Hinterberger-Fischer, M.; Kalhs, P. 1989: Interstitial pneumonia as a cause of early mortality in allogeneic bone marrow transplantation: the Viennese experience Folia Haematologica 116(3-4): 565-567
Elfenbein, G.; Krischer, J.; Babington, R.; Hong, R.; Jansen, J.; Lazarus, H.; Winton, E.; Rand, K. 1989: Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation Transplantation Proceedings 21(1 Pt 3): 3099-3100
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Winston, D.J.; Ho, W.G.; Lin, C.H.; Bartoni, K.; Budinger, M.D.; Gale, R.P.; Champlin, R.E. 1987: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation Annals of Internal Medicine 106(1): 12-18
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
D'Antonio, D.; Iacone, A.; Fioritoni, G.; Dell'Isola, M.; Mastropasqua, L.; Lobefalo, L.; De Nicola, G.C.; Paolone, V.; Di Gregorio, P.; Recchia, A. 1991: Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir) Journal of ChemoTherapy 3(3): 162-166